Witt Lars, Osthaus Wilhelm Alexander, Jahn Wiebke, Rahe-Meyer Niels, Hanke Alexander, Schmidt Florian, Boehne Martin, Sümpelmann Robert
Clinic of Anaesthesiology, Hannover Medical School, Hannover, Germany.
Paediatr Anaesth. 2012 Apr;22(4):379-85. doi: 10.1111/j.1460-9592.2012.03798.x. Epub 2012 Jan 19.
Artificial colloids, frequently used to prevent hemorrhagic shock in children, impair blood coagulation. To determine the impact of acute isovolaemic hemodilution with artificial colloids on clot formation, we conducted an experimental study in a pediatric animal model.
Fifteen piglets underwent hemorrhage by withdrawing 40 ml·kg(-1) of blood volume in steps of 10 ml·kg(-1) each within 1 hour. After each withdrawal, the blood loss was randomly compensated by administering 4% gelatin (GEL) or hydroxylethyl starch 130/0.42 (HES) in a ratio of 1 : 1, or isotonic crystalloid solution (ICS) in a ratio of 1 : 4 for isovolaemic hemodilution. Quality of clot formation and platelet function was measured using Thrombelastometry (ROTEM(®)) and Multiple electrode impedance aggregometry (Multiplate(®)) after 10, 20, and 40 ml·kg(-1) blood replacement.
Moderate hemodilution (10-20 ml·kg(-1) blood replacement) caused no significant differences among groups (e.g. INTEM(®)-MCF after 20 ml·kg(-1) blood replacement (ICS vs GEL vs HES, P > 0.05). Profound hemodilution with 40 ml·kg(-1) blood replacement showed a significant difference between ICS and both colloids (P < 0.05), but no significant differences between GEL and HES.
Impairment of clot formation by moderate isovolaemic hemodilution did not significantly differ between ICS, GEL, and HES. Profound hemodilution of more than 50% of the estimated blood volume with GEL and HES caused significant impairment of clot formation in comparison to ICS and has to be considered when using high amounts of these synthetic colloids.
人工胶体常用于预防儿童失血性休克,但会损害血液凝固功能。为了确定人工胶体进行急性等容血液稀释对凝血形成的影响,我们在儿科动物模型中开展了一项实验研究。
15只仔猪在1小时内按每次10 ml·kg⁻¹的步长抽取40 ml·kg⁻¹血容量进行出血。每次抽血后,随机给予4%明胶(GEL)或羟乙基淀粉130/0.42(HES),比例为1:1,或等渗晶体溶液(ICS),比例为1:4,以进行等容血液稀释来补偿失血。在补充10、20和40 ml·kg⁻¹血液后,使用血栓弹力图(ROTEM(®))和多电极阻抗聚集法(Multiplate(®))测量凝血形成质量和血小板功能。
中度血液稀释(补充10 - 20 ml·kg⁻¹血液)在各组间未引起显著差异(例如,补充20 ml·kg⁻¹血液后的INTEM(®)-MCF(ICS组与GEL组与HES组相比,P > 0.05)。补充40 ml·kg⁻¹血液的深度血液稀释显示ICS与两种胶体之间存在显著差异(P < 0.05),但GEL与HES之间无显著差异。
ICS、GEL和HES在中度等容血液稀释对凝血形成的损害方面无显著差异。与ICS相比,使用GEL和HES进行超过估计血容量50%的深度血液稀释会导致凝血形成显著受损,在使用大量这些合成胶体时必须予以考虑。